Maria Patzwald, diagnosed with pre-eclampsia during her second pregnancy, participated in a pioneering trial aimed at treating the condition by targeting a specific protein, which successfully extended her pregnancy by ten days, significantly improving her baby’s chances of survival at birth. #Pregnancy #PreEclampsia #MaternalHealth #US #DE #GB
Maria Patzwald, a 38-year-old woman diagnosed with severe preeclampsia during her second pregnancy, participated in a pioneering clinical trial that targeted a specific protein believed to cause the condition, leading to a significant extension of her pregnancy by 10 days and an increased survival chance for her premature son. #Pregnancy #Preeclampsia #MedicalResearch #US #DE #GB
Maria Patzwald, a 38-year-old mother, participated in a pioneering trial aimed at treating preeclampsia—which affects many pregnancies and poses serious risks—by targeting a specific protein in the blood, leading to a successful extension of her pregnancy by two weeks and improving the chances of survival for her premature son. #Pregnancy #HealthInnovation #PreEclampsia #US #DE #GB
Maria Patzwald, a 38-year-old woman, shares her experience of being part of a pioneering clinical trial aimed at treating preeclampsia, a potentially fatal pregnancy complication, which helped extend her pregnancy by ten days, leading to the safe birth of her son at 34 weeks, significantly improving his chances of survival. #PregnancyHealth #PreEclampsia #MaternalCare #US #DE #GB
Maria Patzwald, a 38-year-old woman diagnosed with preeclampsia during her second pregnancy, participated in a pioneering trial aimed at treating the condition by targeting a specific protein, which led to her son being born at 34 weeks, significantly increasing his chances of survival. #Pregnancy #Healthcare #PreEclampsia #US #DE #GB
A 38-year-old woman named Maria Patzwald participated in a pioneering trial aimed at treating preeclampsia, a potentially fatal pregnancy complication, and her involvement helped extend her son's gestation by two weeks, significantly improving his chances of survival. #PregnancyCare #MedicalResearch #PreEclampsia #US #DE #GB
Maria Patzwald, a 38-year-old pregnant woman diagnosed with severe preeclampsia, participated in a pioneering trial aimed at treating the condition, which affects maternal and neonatal health, and was able to have her son born at 34 weeks, significantly improving his chances of survival. #PregnancyHealth #PreEclampsia #MaternalHealth #US #DE #GB
A 38-year-old woman named Maria Patzwald participated in a pioneering trial aimed at treating preeclampsia, a serious pregnancy complication, which allowed her to safely extend her pregnancy by 10 days, resulting in her son being born at 34 weeks, significantly improving his chances of survival. #Pregnancy #PreEclampsia #MaternalHealth #US #DE #GB
A 38-year-old woman, Maria Patzwald, participated in a pioneering trial for treating preeclampsia, a serious pregnancy complication, which helped extend her pregnancy by ten days, allowing her son Bennet to be born at 34 weeks, significantly improving his chances of a healthy outcome. #Pregnancy #Preeclampsia #MedicalResearch #US #DE #GB
Maria Patzwald, a 38-year-old mother, credits a pioneering treatment trial for helping manage her severe preeclampsia during pregnancy, which extended her son's gestation by ten days and ultimately allowed him to be born at week 34, significantly increasing his chances of survival. #MaternalHealth #PregnancyResearch #Preeclampsia #US #DE #GB
The article highlights the experiences of renowned Olympic track athlete Allyson Felix and her teammates as they navigated severe pregnancy complications, particularly preeclampsia, shedding light on the increased risks faced by Black and Filipino-American women, and calls for greater awareness and systemic changes in maternal healthcare to prevent unnecessary suffering and death during and after pregnancy. #MaternalHealth #Preeclampsia #PregnancyComplications #US #PH
The article highlights the alarming realities faced by elite female athletes like Allyson Felix, Tianna Madison, and Tori Bowie regarding pregnancy complications, emphasizing the prevalence of conditions like preeclampsia and their significant impacts on both maternal and infant health, while advocating for improved maternal protections in sports and better access to prenatal care to prevent unnecessary deaths. #MaternalHealth #Preeclampsia #WomenInSports #USA #FIL
The article highlights the experiences of Olympians Allyson Felix, Tianna Madison, and Tori Bowie, who faced severe pregnancy complications, including preeclampsia and eclampsia, leading to life-threatening situations and, in Bowie's case, death, while also addressing the systemic issues that endanger maternal health, especially among women of color, and advocating for improved maternal protections and support within the sports industry and healthcare system. #MaternalHealth #Preeclampsia #AthleteMothers #US
The article highlights the serious complications faced by elite female athletes during and after pregnancy, focusing on the experiences of Allyson Felix and her teammates who encountered life-threatening conditions like preeclampsia and its impacts on their health and careers, while advocating for increased maternal protections and awareness in the sports industry. #MaternalHealth #Preeclampsia #WomenInSports #US #PH
A pioneering study published in Nature Medicine suggests that a blood filtration technique, known as apheresis, can safely reduce levels of the placental protein sFlt-1 and lower blood pressure in early-onset severe preeclampsia, potentially delaying disease progression and improving outcomes for both mother and baby, although larger controlled trials are needed to confirm these findings. #Preeclampsia #PregnancyHealth #MedicalResearch #Nocountrycodesarementionedinthearticle.
Current treatments for very early-stage preeclampsia, including corticosteroids and magnesium sulfate, do not safely prolong pregnancy, but an international research team has successfully tested a blood filtration technique called apheresis to reduce levels of the placental protein sFlt-1, potentially slowing disease progression and allowing for longer pregnancies without harming mothers or babies. #Preeclampsia #Pregnancy #MedicalResearch #GB #DE #AU #US
